osteoporosis

FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
FDA rejects Amgen’s osteoporosis drug romo as rival Radius surprises with a new CEO
Endpoints
FDA
Amgen
osteoporosis
romosozumab
UCB Pharma
Radius Health
Tymlos
Flag link:
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Amgen's romosozumab red flag on heart safety means a boost for new Radius bone drug
Fierce Pharma
Amgen
romosozumab
Radius Health
UCB Pharma
Tymlos
osteoporosis
Flag link:
With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry
With Amgen hot on its heels, Radius races to get a jump on osteoporosis drug rivalry
Endpoints
Amgen
Radius Health
osteoporosis
Tymlos
romosozumab
Flag link:
FDA approves Radius Health's osteoporosis drug Tymlos
FDA approves Radius Health's osteoporosis drug Tymlos
Yahoo/Reuters
FDA
Radius Health
osteoporosis
Tymlos
Flag link:
Court Revives Claims Against Merck Osteoporosis Drug
Court Revives Claims Against Merck Osteoporosis Drug
Investopedia
Merck
osteoporosis
thigh fractures
Fosamax
Flag link:
Radius shares slide after FDA delays decision on bone drug
Radius shares slide after FDA delays decision on bone drug
BioPharma Dive
Radius Health
FDA
abaloparatide
osteoporosis
Flag link:
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Dr. Reddy's Labs Launches Generic Osteoporosis Drug Tablets in the US
Yahoo
Dr Reddy's
generics
osteoporosis
Eli Lilly
Evista
Flag link:
Amgen's Osteoporosis Drug Crosses a Hurdle
Amgen's Osteoporosis Drug Crosses a Hurdle
Investopedia
Amgen
osteoporosis
romosozumab
Flag link:
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Amgen’s expectations for romosozumab take a hit as Radius lines up its rival osteoporosis drug
Endpoints
Amgen
romosozumab
Radius Health
abaloparatide
osteoporosis
Flag link:
Merck scraps development of osteoporosis drug due to stroke risk
Merck scraps development of osteoporosis drug due to stroke risk
Yahoo/Reuters
Merck
osteoporosis
stroke
Odanacatib
Flag link:
Split the pot? Radius shows its osteoporosis cards in final blockbuster match with Amgen
Split the pot? Radius shows its osteoporosis cards in final blockbuster match with Amgen
Endpoints
Amgen
Radius Health
osteoporosis
abaloparatide
romosozumab
Flag link:
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Amgen’s Bone Health Drug Saw Strong Revenue Growth in 2Q16
Market Realist
Amgen
Prolia
Xgeva
osteoporosis
Flag link:
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
Merck and Premier Inc. Collaborate to Prevent Fractures for Osteoporosis Patients
Yahoo
Merck
osteoporosis
Premier
Flag link:
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
Amgen's bone-building osteo drug dazzles in phase 3, but could face hefty competition
BioPharma Dive
romosozumab
Amgen
osteoporosis
clinical trials
Eli Lilly
Forteo
Radius Health
abaloparatide
Flag link:
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
Yahoo/Reuters
Amgen
UCB Pharma
osteoporosis
clinical trials
romosozumab
Flag link:
Zosano loses its big Eli Lilly deal, and its stock is eviscerated
Zosano loses its big Eli Lilly deal, and its stock is eviscerated
Fierce Biotech
Zosano
Eli Lilly
ZP-PTH
osteoporosis
Flag link:
Amgen's bone drug succeeds in late-stage study
Amgen's bone drug succeeds in late-stage study
Yahoo/Reuters
Amgen
osteoporosis
romosozumab
Flag link:
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Amgen Bone Drug Can Lead Market; Over 15% Upside Expected
Bidness, ETC
Amgen
romosozumab
osteoporosis
Flag link:
Lilly buys into Zosano's osteoporosis patch
Lilly buys into Zosano's osteoporosis patch
Pharma Times
Eli Lilly
Zosano
osteoporosis
ZP-PTH
Flag link:
Side effect fears weigh on Merck osteoporosis drug
Side effect fears weigh on Merck osteoporosis drug
Pharmaphorum
Merck
osteoporosis
Odanacatib
Flag link: